Stanozolol antibody
Quick Overview for Stanozolol antibody (ABIN1001505)
Target
Reactivity
Host
Clonality
Conjugate
Application
-
-
Purpose
- Stanozolol
-
Specificity
- Compound % Cross-Reactivity Stanozolol 100 16 beta-Hydroxystanozolol 40 4 alpha-Hydroxystanozolol 0.9 3-Hydroxy-17-Epi-Stanozolol < 0.1 3-Hydroxystanozolol < 0.1 19-Nortestosterone (17alpha) < 0.1 19-Nortestosterone (17beta) < 0.1 Trenbolone (17alpha) < 0.1 Trenbolone (17beta) < 0.1 19-Nor-4-Androstene -3,17-Dione< 0.1 Boldenone < 0.1 Progesterone < 0.1 Testosterone (17beta) < 0.1 Cortisol < 0.1 Estriol < 0.1 Estrone < 0.1 Danazol < 0.1 Methandriol < 0.1 17alpha-Methyltesterone < 0.1
-
Purification
- Salt fractionation.
-
Immunogen
- Stanozolol-BSA
-
Isotype
- IgG
-
-
-
-
Application Notes
-
Application_Dilutions: 1/2K
Tested_Applications: The antibody is suitable for the development of immunoassays or immunoaffinity purification columns.
-
Comment
-
10 ng/mL Stanozolol produces 52 % inhibition in a competitive ELISA employing Stanozolol polyclonal antibody.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- 20 mM Phosphate, 150 mM Sodium Chloride. pH 7.4, 0.09 % Sodium Azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Can be stored for up to 3 months at +2°C - +8°C. For long term storage, aliquot and store at ≤-20 °C. Avoid repeated freeze/thaw cycles. Product should be protected from light exposure.
-
-
- Stanozolol
-
Target Type
- Hormone
-
Background
- Stanozolol is an androgenic anabolic steroid used in cases of deficiency in protein synthesis and osteoporosis.
Target
-